Skip to main content
DuChemBio Co, LTD logo

DuChemBio Co, LTD — Investor Relations & Filings

Ticker · 176750 ISIN · KR7176750008 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2021-12-15 Director's Dealing
Country KR South Korea
Listing KO 176750

About DuChemBio Co, LTD

http://www.duchembio.com/en/

DuChemBio Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of radiopharmaceuticals. The company focuses on products for both diagnosis and treatment, with a primary emphasis on positron emission tomography (PET) imaging tracers. Its portfolio targets key therapeutic areas, including oncology for cancer detection and neurology for conditions such as Alzheimer's and Parkinson's disease. The company's mission is to develop novel radiopharmaceuticals and achieve successful commercialization on a global scale.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is used to disclose insider transactions (purchases or sales of shares by directors or major shareholders). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2021-12-15 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or the meeting results, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given it is a specific regulatory notification that does not fit into the other categories, it is classified as a general regulatory filing.
2021-12-09 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a short, structured announcement (under 1,000 characters) detailing the results of an Investor Relations (IR) event held on 2021-11-18. It provides logistical details such as the date, location (online platforms), attendees, and a summary of the topics covered. It does not contain the actual presentation slides or full financial data, but rather serves as a notification that the event occurred and where the materials can be found. Following the 'Menu vs Meal' rule, this is a report publication/event announcement rather than the presentation itself, fitting the 'Report Publication Announcement' (RPA) category.
2021-11-18 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company 'DuChemBio'. It details the voting outcome regarding the appointment of a new director (Kim Jin-tae). Since it reports the official results of a shareholder meeting, it falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-11-01 Korean
[기재정정]최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (DuChemBio) regarding a change in the largest shareholder (major shareholding notification). It details the change in ownership structure, the reason for the change (merger), and the resulting impact on the board of directors. This falls under the category of major shareholding notifications as it reports a significant change in ownership threshold and control.
2021-10-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (임시주주총회소집공고) for DuChemBio. It includes the meeting agenda, date, location, and procedural information for shareholders. While it contains some management report data (Section I, II, III), the primary purpose of the document is to formally notify shareholders of an upcoming meeting and provide the necessary information for voting, which aligns with the definition of a Proxy Solicitation & Information Statement.
2021-10-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.